Hempstract Performance
| HPSTDelisted Stock | USD 0.13 0.03 18.75% |
The company retains a Market Volatility (i.e., Beta) of -2.01, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Hempstract are expected to decrease by larger amounts. On the other hand, during market turmoil, Hempstract is expected to outperform it. Hempstract right now retains a risk of 0.0%. Please check out Hempstract maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Hempstract will be following its current trending patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Hempstract has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Hempstract is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Hempstract |
Hempstract Relative Risk vs. Return Landscape
If you would invest 13.00 in Hempstract on October 20, 2025 and sell it today you would earn a total of 0.00 from holding Hempstract or generate 0.0% return on investment over 90 days. Hempstract is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Hempstract, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Hempstract Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hempstract's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Hempstract, and traders can use it to determine the average amount a Hempstract's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HPST |
Based on monthly moving average Hempstract is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hempstract by adding Hempstract to a well-diversified portfolio.
Hempstract Fundamentals Growth
Hempstract Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Hempstract, and Hempstract fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hempstract Pink Sheet performance.
| Return On Equity | -0.57 | |||
| Return On Asset | -0.0644 | |||
| Profit Margin | (0.35) % | |||
| Operating Margin | (0.40) % | |||
| Current Valuation | 2.33 M | |||
| Revenue | 12.56 K | |||
| Cash And Equivalents | 9.57 K | |||
| Total Debt | 75 | |||
| Debt To Equity | 0 % | |||
About Hempstract Performance
Assessing Hempstract's fundamental ratios provides investors with valuable insights into Hempstract's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Hempstract is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Hempstract, Inc. produces and sells cannabidiol and cannabigerol solutions in the United States. The company was formerly known as Riverdale Oil and Gas Corporation and changed its name to Hempstract, Inc. in November 2020. Hempstract is traded on OTC Exchange in the United States.Things to note about Hempstract performance evaluation
Checking the ongoing alerts about Hempstract for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Hempstract help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hempstract is not yet fully synchronised with the market data | |
| Hempstract has some characteristics of a very speculative penny stock | |
| Hempstract has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.56 K. Net Loss for the year was (4.43 K) with profit before overhead, payroll, taxes, and interest of 1.7 K. |
- Analyzing Hempstract's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hempstract's stock is overvalued or undervalued compared to its peers.
- Examining Hempstract's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hempstract's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hempstract's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hempstract's pink sheet. These opinions can provide insight into Hempstract's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Hempstract Pink Sheet
If you are still planning to invest in Hempstract check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hempstract's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |